AKR1B10 and lung adenocarcinoma: We evaluated the clinical significance of AKR1B10 using the GPL570 platform dataset (Figure 3C), a microarray platform developed by Affymetrix for gene expression profiling commonly referred to as the Affymetrix Human Genome U133 Plus 2.0 Array, and the GDC TCGA LUAD dataset (Figure 3D), a comprehensive genome, and clinical data of lung adenocarcinoma (LUAD) collected and made available by the Cancer Genome Atlas (TCGA) through the Genomic Data Commons (GDC).